BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28283200)

  • 1. Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs.
    Munguia J; Nizet V
    Trends Pharmacol Sci; 2017 May; 38(5):473-488. PubMed ID: 28283200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract.
    Domenech M; Sempere J; de Miguel S; Yuste J
    Front Immunol; 2018; 9():2700. PubMed ID: 30515172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Antibiotic Tolerance, Pathogen by Pathogen.
    Meylan S; Andrews IW; Collins JJ
    Cell; 2018 Mar; 172(6):1228-1238. PubMed ID: 29522744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host-dependent Induction of Transient Antibiotic Resistance: A Prelude to Treatment Failure.
    Kubicek-Sutherland JZ; Heithoff DM; Ersoy SC; Shimp WR; House JK; Marth JD; Smith JW; Mahan MJ
    EBioMedicine; 2015 Sep; 2(9):1169-78. PubMed ID: 26501114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Man vs Microbes - The Race of the Century.
    Anderson E; Nair B; Nizet V; Kumar G
    J Med Microbiol; 2023 Jan; 72(1):. PubMed ID: 36748622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges.
    Chiang CY; Uzoma I; Moore RT; Gilbert M; Duplantier AJ; Panchal RG
    mBio; 2018 Jan; 9(1):. PubMed ID: 29382729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic efficacy in the complex infection environment.
    Radlinski L; Conlon BP
    Curr Opin Microbiol; 2018 Apr; 42():19-24. PubMed ID: 28988156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-bacterial monoclonal antibodies: next generation therapy against superbugs.
    Wang H; Chen D; Lu H
    Appl Microbiol Biotechnol; 2022 Jun; 106(11):3957-3972. PubMed ID: 35648146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siderophores in Iron Metabolism: From Mechanism to Therapy Potential.
    Wilson BR; Bogdan AR; Miyazawa M; Hashimoto K; Tsuji Y
    Trends Mol Med; 2016 Dec; 22(12):1077-1090. PubMed ID: 27825668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Exploiting Novel Combined Host- and Pathogen-Directed Therapies for Combating Bacterial Multidrug Resistance.
    Nisini R; Oggioni MR; Rossolini GM; Fraziano M
    Front Immunol; 2020; 11():616486. PubMed ID: 33250904
    [No Abstract]   [Full Text] [Related]  

  • 11. Bacterial genome engineering and synthetic biology: combating pathogens.
    Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
    BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards efficient immunotherapy for bacterial infection.
    McCulloch TR; Wells TJ; Souza-Fonseca-Guimaraes F
    Trends Microbiol; 2022 Feb; 30(2):158-169. PubMed ID: 34253452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to prevent the occurrence of resistance against antibiotics by using advanced materials.
    Bassegoda A; Ivanova K; Ramon E; Tzanov T
    Appl Microbiol Biotechnol; 2018 Mar; 102(5):2075-2089. PubMed ID: 29392390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aligning antimicrobial drug discovery with complex and redundant host-pathogen interactions.
    Lebeis SL; Kalman D
    Cell Host Microbe; 2009 Feb; 5(2):114-22. PubMed ID: 19218083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.
    Ram S; Shaughnessy J; DeOliveira RB; Lewis LA; Gulati S; Rice PA
    Immunobiology; 2016 Oct; 221(10):1110-23. PubMed ID: 27297292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.
    Wong JP; DiTullio P; Parkinson S
    Future Microbiol; 2015; 10(11):1751-8. PubMed ID: 26597426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of Antibiotic Resistance.
    Munita JM; Arias CA
    Microbiol Spectr; 2016 Apr; 4(2):. PubMed ID: 27227291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial monoclonal antibodies: the next generation?
    DiGiandomenico A; Sellman BR
    Curr Opin Microbiol; 2015 Oct; 27():78-85. PubMed ID: 26302478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic strategies to combat antibiotic resistance.
    Brooks BD; Brooks AE
    Adv Drug Deliv Rev; 2014 Nov; 78():14-27. PubMed ID: 25450262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.